RCKT icon

Rocket Pharmaceuticals

146 hedge funds and large institutions have $1.85B invested in Rocket Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 55 increasing their positions, 49 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership:

less funds holding

Funds holding:

less funds holding in top 10

Funds holding in top 10:

25% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 16

32% less capital invested

Capital invested by funds: $2.74B → $1.85B (-$888M)

Holders
146
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$3.68M
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$44.4M
2 +$24.1M
3 +$17.3M
4
NHAS
Novo Holdings A/S
Denmark
+$16M
5
Citadel Advisors
Citadel Advisors
Florida
+$15M

Top Sellers

1 -$39.8M
2 -$26.1M
3 -$15.5M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$14M
5
PA
Perceptive Advisors
New York
-$13.2M
Name Holding Trade Value Shares
Change
Change in
Stake
26
$12.4M
27
$12.1M
28
$11.2M
29
$10.5M
30
$9.91M
31
$9.07M
32
$8.19M
33
$7.87M
34
$6.26M
35
$6.21M
36
$5.99M
37
$5.92M
38
$5.81M
39
$5.54M
40
$5.07M
41
$4.95M
42
$4.87M
43
$4.43M
44
$3.84M
45
$3.45M
46
$3.42M
47
$2.91M
48
$2.87M
49
$2.87M
50
$2.64M